Myotonia congenita is a congenital neuromuscular channelopathy that affects skeletal muscles, characterized by the failure of an initiated muscle contraction to terminate, which produces prolonged muscle stiffness and delayed relaxation. It is caused by mutations in the CLCN1 gene, which encodes the ClC-1 chloride channel; these loss of function mutations make muscle fiber membranes hyperexcitable and prevent normal relaxation after contraction. Patients experience delayed relaxation following voluntary contraction, muscle stiffness, muscle enlargement, and in some cases transient weakness, with complications including severe jaw muscle spasms, cramping, and an increased risk of falls. There are two main forms. Thomsen disease is autosomal dominant, clinically apparent from birth, and generally causes milder symptoms affecting the face, hands, and eyelids; it was named after Danish physician Asmus Julius Thomsen, who described it in 1876. Becker disease is autosomal recessive, appears later in childhood, and causes more severe myotonia and muscle stiffness, with patients experiencing temporary attacks of weakness that can become permanent over time.
Facts
Classification
ICD-10 ChapterVI: Diseases of the Nervous System 1 Communicable or Non-communicable Causative Agent
Causative Agent (category) First Described Sources
1. Myotonia Congenita (Wikipedia)
Lead
A congenital neuromuscular channelopathy that affects skeletal muscles.
Lead, genetic cause
Three cases have been reported who were diagnosed with Thomsen's myotonia and proved on genetic testing not to have mutations in the chloride gene but rather in the alpha-subunit of the voltage gated sodium channel (SCN4A). This is the gene encoding the protein CLCN1, that forms the ClC-1 chloride channel, critical for the normal function of skeletal muscle cells.
Thomsen disease section
Autosomal dominant myotonia congenita (OMIM #160800) is also called Thomsen disease, after Danish/German physician Asmus Julius Thomas Thomsen (1815-1896), who himself had the disease and who wrote the first description of it in the medical literature (in 1876).
View the SourceReader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.